% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 106

Loading Chart...

2 inventors (with patents filed for the assignee):

Dennis Bang Henriksen (4 out of 8 patents)

Jens Juul Holst (3 out of 8 patents)

4 patents: Sort by Forward Citations

1. 7371721 - Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes (2008-05-13),

2. 7186683 - Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders (2007-03-06),

3. 6943151 - Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds (2005-09-13),

4. 6770620 - Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders (2004-08-03),

Company Overview

Sanos Bioscience A/S is a leading biotechnology company focused on developing innovative solutions for the healthcare industry. With a strong emphasis on research and development, we are dedicated to creating cutting-edge products that improve patient outcomes and quality of life. Our team of experts are committed to driving advancements in medical technology and biopharmaceuticals.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#15 in Herlev

#551 in Denmark

Herlev, Denmark

Sanos Bioscience A/s

Forward Citations = 106

2 inventors:

Dennis Bang Henriksen (4 out of 8 patents)

Jens Juul Holst (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sanos Bioscience A/s. Retrieved from https://idiyas.com/company/sanos-bioscience-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]